Cargando…

The NARCONON™ drug education curriculum for high school students: A non-randomized, controlled prevention trial

BACKGROUND: An estimated 13 million youths aged 12 to 17 become involved with alcohol, tobacco and other drugs annually. The number of 12- to 17-year olds abusing controlled prescription drugs increased an alarming 212 percent between 1992 and 2003. For many youths, substance abuse precedes academic...

Descripción completa

Detalles Bibliográficos
Autores principales: Lennox, Richard D, Cecchini, Marie A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2330037/
https://www.ncbi.nlm.nih.gov/pubmed/18348735
http://dx.doi.org/10.1186/1747-597X-3-8
_version_ 1782152777858809856
author Lennox, Richard D
Cecchini, Marie A
author_facet Lennox, Richard D
Cecchini, Marie A
author_sort Lennox, Richard D
collection PubMed
description BACKGROUND: An estimated 13 million youths aged 12 to 17 become involved with alcohol, tobacco and other drugs annually. The number of 12- to 17-year olds abusing controlled prescription drugs increased an alarming 212 percent between 1992 and 2003. For many youths, substance abuse precedes academic and health problems including lower grades, higher truancy, drop out decisions, delayed or damaged physical, cognitive, and emotional development, or a variety of other costly consequences. For thirty years the Narconon program has worked with schools and community groups providing single educational modules aimed at supplementing existing classroom-based prevention activities. In 2004, Narconon International developed a multi-module, universal prevention curriculum for high school ages based on drug abuse etiology, program quality management data, prevention theory and best practices. We review the curriculum and its rationale and test its ability to change drug use behavior, perceptions of risk/benefits, and general knowledge. METHODS: After informed parental consent, approximately 1000 Oklahoma and Hawai'i high school students completed a modified Center for Substance Abuse Prevention (CSAP) Participant Outcome Measures for Discretionary Programs survey at three testing points: baseline, one month later, and six month follow-up. Schools assigned to experimental conditions scheduled the Narconon curriculum between the baseline and one-month follow-up test; schools in control conditions received drug education after the six-month follow-up. Student responses were analyzed controlling for baseline differences using analysis of covariance. RESULTS: At six month follow-up, youths who received the Narconon drug education curriculum showed reduced drug use compared with controls across all drug categories tested. The strongest effects were seen in all tobacco products and cigarette frequency followed by marijuana. There were also significant reductions measured for alcohol and amphetamines. The program also produced changes in knowledge, attitudes and perception of risk. CONCLUSION: The eight-module Narconon curriculum has thorough grounding in substance abuse etiology and prevention theory. Incorporating several historically successful prevention strategies this curriculum reduced drug use among youths.
format Text
id pubmed-2330037
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-23300372008-04-24 The NARCONON™ drug education curriculum for high school students: A non-randomized, controlled prevention trial Lennox, Richard D Cecchini, Marie A Subst Abuse Treat Prev Policy Research BACKGROUND: An estimated 13 million youths aged 12 to 17 become involved with alcohol, tobacco and other drugs annually. The number of 12- to 17-year olds abusing controlled prescription drugs increased an alarming 212 percent between 1992 and 2003. For many youths, substance abuse precedes academic and health problems including lower grades, higher truancy, drop out decisions, delayed or damaged physical, cognitive, and emotional development, or a variety of other costly consequences. For thirty years the Narconon program has worked with schools and community groups providing single educational modules aimed at supplementing existing classroom-based prevention activities. In 2004, Narconon International developed a multi-module, universal prevention curriculum for high school ages based on drug abuse etiology, program quality management data, prevention theory and best practices. We review the curriculum and its rationale and test its ability to change drug use behavior, perceptions of risk/benefits, and general knowledge. METHODS: After informed parental consent, approximately 1000 Oklahoma and Hawai'i high school students completed a modified Center for Substance Abuse Prevention (CSAP) Participant Outcome Measures for Discretionary Programs survey at three testing points: baseline, one month later, and six month follow-up. Schools assigned to experimental conditions scheduled the Narconon curriculum between the baseline and one-month follow-up test; schools in control conditions received drug education after the six-month follow-up. Student responses were analyzed controlling for baseline differences using analysis of covariance. RESULTS: At six month follow-up, youths who received the Narconon drug education curriculum showed reduced drug use compared with controls across all drug categories tested. The strongest effects were seen in all tobacco products and cigarette frequency followed by marijuana. There were also significant reductions measured for alcohol and amphetamines. The program also produced changes in knowledge, attitudes and perception of risk. CONCLUSION: The eight-module Narconon curriculum has thorough grounding in substance abuse etiology and prevention theory. Incorporating several historically successful prevention strategies this curriculum reduced drug use among youths. BioMed Central 2008-03-19 /pmc/articles/PMC2330037/ /pubmed/18348735 http://dx.doi.org/10.1186/1747-597X-3-8 Text en Copyright © 2008 Lennox and Cecchini; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Lennox, Richard D
Cecchini, Marie A
The NARCONON™ drug education curriculum for high school students: A non-randomized, controlled prevention trial
title The NARCONON™ drug education curriculum for high school students: A non-randomized, controlled prevention trial
title_full The NARCONON™ drug education curriculum for high school students: A non-randomized, controlled prevention trial
title_fullStr The NARCONON™ drug education curriculum for high school students: A non-randomized, controlled prevention trial
title_full_unstemmed The NARCONON™ drug education curriculum for high school students: A non-randomized, controlled prevention trial
title_short The NARCONON™ drug education curriculum for high school students: A non-randomized, controlled prevention trial
title_sort narconon™ drug education curriculum for high school students: a non-randomized, controlled prevention trial
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2330037/
https://www.ncbi.nlm.nih.gov/pubmed/18348735
http://dx.doi.org/10.1186/1747-597X-3-8
work_keys_str_mv AT lennoxrichardd thenarconondrugeducationcurriculumforhighschoolstudentsanonrandomizedcontrolledpreventiontrial
AT cecchinimariea thenarconondrugeducationcurriculumforhighschoolstudentsanonrandomizedcontrolledpreventiontrial
AT lennoxrichardd narconondrugeducationcurriculumforhighschoolstudentsanonrandomizedcontrolledpreventiontrial
AT cecchinimariea narconondrugeducationcurriculumforhighschoolstudentsanonrandomizedcontrolledpreventiontrial